Literature DB >> 3772449

CSF brain creatine kinase levels and lactic acidosis in severe head injury.

L Rabow, A F DeSalles, D P Becker, M Yang, H A Kontos, J D Ward, R J Moulton, G Clifton, H D Gruemer, J P Muizelaar.   

Abstract

The posttraumatic creatine kinase-BB isoenzyme (CKBB) activity and lactate concentration in ventricular cerebrospinal fluid (CSF) have been studied in 29 patients with severe head injuries. The CKBB activity reaches its maximum a few hours after trauma, and has a monoexponential drop with a half-time of approximately 10 hours. Ventricular CSF lactate concentration continues to rise in patients with a poor outcome, and decreases only slowly and inconsistently in most of the other patients. Thus, increase of lactate in the ventricular CSF is not, like CKBB, a direct one-stage consequence of the trauma but is due to continuous production from a derangement of metabolism caused by the trauma. Since even higher ventricular CSF lactate levels can be survived when not caused by head injury, and since no significant pH changes were related to the ventricular CSF lactic acidosis in these artificially ventilated patients, it is concluded that ventricular CSF lactic acidosis is indicative of a severe, although not necessarily intractable, disturbance of brain function associated with intracellular lactate production and acidosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772449     DOI: 10.3171/jns.1986.65.5.0625

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Enzymatic changes in the cerebrospinal fluid as indices of pathological change.

Authors:  A Paşaoğlu; H Paşaoğlu
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Abstracted proceedings: Symposium on Central Nervous System Monitoring. May 28-30, 1987, Gmunden, Austria.

Authors: 
Journal:  J Clin Monit       Date:  1987-10

3.  Cerebral lactate production in relation to intracranial pressure, cranial computed tomography findings, and outcome in patients with severe head injury.

Authors:  R Murr; W Stummer; L Schürer; J Polasek
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients.

Authors:  B Young; L Ott; R Dempsey; D Haack; P Tibbs
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

5.  Creatine-kinase-BB after severe head-injury as an index of prognosis in relation to nature of trauma and patients age.

Authors:  A Niedeggen; D Adelt; R Berndt; T Hopf
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

6.  Relationship between CT attenuation changes and post-traumatic CSF-CKBB-activity after severe head injury in man.

Authors:  L Rabow; D Cook; M H Lipper; A A DeSalles; H D Gruemer; A Marmarou; D P Becker
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

7.  Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation.

Authors:  A Kruse; K G Cesarini; F W Bach; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

8.  Identifying traumatic brain injury in patients with isolated head trauma: are arterial lactate and base deficit as helpful as in polytrauma?

Authors:  Shahriar Zehtabchi; Richard Sinert; Samara Soghoian; Yiju Liu; Kristin Carmody; Lekha Shah; Mridul Kumar; Michael Lucchesi
Journal:  Emerg Med J       Date:  2007-05       Impact factor: 2.740

9.  Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury.

Authors:  Stephen W Scheff; Harabhajan S Dhillon
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

10.  Does a routine operation for intracranial aneurysm incur brain damage?

Authors:  L Rabow; G Algers; J Elfversson; P A Ridderheim; O Rudolphi; S Zygmunt
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.